The next generation sequencing market size, valued at USD 7.7 billion in 2024, is estimated to reach USD 8.6 billion in 2025 and USD 46.5 billion by 2035. The market is anticipated to grow at a CAGR of 18.4%, during the forecast period till 2035. This growth is calculated based on observed trends, actual industry performance, and current developments in product usage and adoption. The study considers the challenges faced by key players and the general market structure, while avoiding speculative interpretations. It focuses on providing a clear picture of market performance across different regions and segments. Type of Technology Used Sequencing by Synthesis Technology Ion Semiconductor Technology Nanopore Sequencing Technology Other Technologies Application Area Clinical Applications Research and Applied Applications Target Therapeutic Area Oncological Disorders Genetic Disorders Reproductive Disorders Other Therapeutic Areas Purpose Diagnosis Risk Assessment Presymptomatic Assessment Screening Other Purposes End Users Academic and Research Institutes Hospitals and Clinics Pharmaceutical and Biotechnology Companies Other End Users Geographical Regions North America Europe Asia-Pacific Middle East and North Africa Latin America Market in North America US Canada Market in Europe Germany France Italy Spain UK Rest of Europe Market in Asia-Pacific China India Japan South Korea Singapore Rest of Asia-Pacific Market in Middle East and North Africa Egypt Israel Saudi Arabia Rest of Middle East and North Africa Market in Latin America Brazil Argentina Rest of Latin America Key Next Generation Sequencing Companies Profiled Admera Health Applied Biological Materials BGI Genomics CD Genomics DNA Link Eurofins Genomics Gene by Gene GENEWIZ MedGenome Novogene Psomagen Veritas Xcelris Labs https://www.rootsanalysis.com/reports/next-generation-sequencing/290.html
Post a Message
All images and sayings (with exception to the Bible verses) have been copyrighted by wordsdomatter.com. Any unauthorized use of these images/sayings is prohibited. Permission is available; please contact us at 317-724-9702 or email at contact@wordsdomatter.com
